Evidence map›Paper›PMID 42310094›Full record

ArticleScientific reports2026

TriPath3DNet: an efficient real-time model for multi-class classification in real-life surveillance videos of fixed duration.

K Mohanarangan, P Palanisamy

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

K MohanaranganDepartment of Electronics and Communication Engineering, National Institute of Technology, Tiruchirappalli, 620015, India. mohan.search@gmail.com.
P PalanisamyDepartment of Electronics and Communication Engineering, National Institute of Technology, Tiruchirappalli, 620015, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper presents TriPath3DNet, a novel, efficient, and interpretable 3D CNN architecture designed for real-time, multi-class classification of short, motion-triggered surveillance video clips under challenging real-world conditions-including occlusion, variable lighting, adverse weather, and subtle low-motion anomalies such as loitering or zone intrusion. TriPath3DNet integrates three complementary temporal pathways-short-term motion, long-term context, and Temporal Difference Encoding (TDE)-into a lightweight ResNet3D (R3D)-18 backbone to jointly model transient dynamics and sustained activities. Evaluated on four datasets-including the newly curated Virat1-RC, Virat2-RC, UCF-Crime, and our proprietary In-House Dataset (IHD)-TriPath3DNet achieves state-of-the-art or near state-of-the-art performance, with up to 95.37% accuracy, 99.42% AUC, and an inference latency of 129 to 137 ms per 50-frame clip (approx 2.6 ms per frame) on an 11 GB GPU, using only 33.46 M parameters. Notably, it outperforms both CNN- and transformer-based baselines-including MViTv1, MViTv2, and VideoSwin-by significant margins, especially on anomaly-dense benchmarks like UCF-Crime, where most vision transformers struggle. While MViTv2 achieves slightly higher accuracy on IHD (91.87% vs. 89.46%), TriPath3DNet delivers substantially better AUC (98.07% vs. 90.96%), indicating superior calibration for critical anomaly detection. Ablation studies confirm that each temporal branch contributes meaningfully to performance, and Grad-CAM visualizations demonstrate spatially precise and temporally coherent attention maps. By aligning architectural design with edge-cloud deployment constraints and the operational realities of industrial surveillance, our work bridges the gap between academic research and real-world video analytics.

Identifiers

PMID42310094
PMCPMC13547256

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.